{
    "@graph": [
        {
            "@id": "gnd:36158-6",
            "sameAs": "Ernst-Moritz-Arndt-Universität Greifswald"
        },
        {
            "@id": "gnd:4024654-1",
            "sameAs": "Herzinfarkt"
        },
        {
            "@id": "gnd:4024655-3",
            "sameAs": "Herzinsuffizienz"
        },
        {
            "@id": "gnd:4129182-7",
            "sameAs": "Carnitin"
        },
        {
            "@id": "gnd:4140660-6",
            "sameAs": "Tiermodell"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A847943453",
            "@type": "bibo:Thesis",
            "P1053": "1 Online-Ressource (PDF-Datei: 118 Seiten, 30878 Kilobyte)",
            "http://purl.org/dc/elements/1.1/creator": "Bonitz, Karina",
            "description": "Illustrationen (farbig), Diagramme (teilweise farbig)",
            "identifier": [
                "(firstid)GBV:847943453",
                "(ppn)847943453"
            ],
            "subject": [
                "(classificationName=bk, id=106409417)44.85 - Kardiologie, Angiologie",
                "(classificationName=linseach:mapping)meda",
                "(classificationName=bk, id=106409743)44.38 - Pharmakologie",
                "(classificationName=ddc-dbn)540"
            ],
            "title": "Bedeutung des Carnitin-Transporters OCTN2 für die Entwicklung einer Herzinsuffizienz und eines akuten Myokardinfarktes",
            "abstract": [
                "Cardiovascular diseases belong to the leading causes of death in Western civilization. Despite multiple therapeutic options, morbidity and mortality of heart failure and ischemic diseases remain high. Patients with dilative cardiomyopathy (DCM) show a clearly reduced gene expression of the carnitine transporter OCTN2. This reduction correlates with a decreased ejection fraction (EF) and might represent a potential risk factor for the development or progression of the DCM. Physiological OCTN2 mediated carnitine uptake is of particular importance for the cellular energy metabolism by betaoxidation. In addition to this endogenous compound OCTN2 also transports various other drug substances like mildronate, which inhibits carnitine uptake. Therefore, one aim of the present study was to verify the influence of a diminished OCTN2 function on the DCM development using hemodynamic analyses like MRI and conductance catheter technique. Therefore mice with homozygous or heterozygous Octn2 deficiency (so-called juvenile viscerale steatosis mice) and corresponding control mice were used as model animals. The content of free carnitine in serum and cardiac tissue as well as hemodynamic parameters (like EF, LVRI and dP/dtmin) of the heterozygous deficient animals varied only slightly in relation to the control animals. Modulation of the carnitine content by pharmacological intervention with mildronate resulted in reduced carnitine levels, but did not influence the cardiac function ...",
                "Carnitin, Herzinsuffizienz, Herzinfarkt, Tiermodell"
            ],
            "contributor": "Technische Informationsbibliothek (TIB)",
            "creator": "gnd:36158-6",
            "isPartOf": "(collectioncode)GBV-ODiss",
            "issued": "2015",
            "language": "http://id.loc.gov/vocabulary/iso639-1/de",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "dcterms:subject": [
                {
                    "@id": "gnd:4140660-6"
                },
                {
                    "@id": "gnd:4129182-7"
                },
                {
                    "@id": "gnd:4024654-1"
                },
                {
                    "@id": "gnd:4024655-3"
                }
            ],
            "P60163": "Greifswald"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "abstract": "http://purl.org/dc/terms/abstract",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "description": "http://purl.org/dc/elements/1.1/description",
        "title": "http://purl.org/dc/elements/1.1/title",
        "creator": {
            "@id": "http://purl.org/dc/terms/creator",
            "@type": "@id"
        },
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "contributor": "http://purl.org/dc/terms/contributor",
        "issued": "http://purl.org/dc/terms/issued",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "license": "http://purl.org/dc/terms/license",
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}